Ibnsina Pharma (EGX: ISPH)

Ibnsina Pharma Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,210	1,131	541.21	468.54	270.88	118.46
Cash & Short-Term Investments	1,210	1,131	541.21	468.54	270.88	118.46
Cash Growth	-	108.93%	15.51%	72.97%	128.66%	22.61%
Accounts Receivable	12,305	9,761	5,775	5,743	3,267	2,517
Other Receivables	0.01	0.01	0.07	-	0.37	0.37
Receivables	12,305	9,761	5,775	5,743	4,831	4,458
Inventory	4,435	3,195	2,614	2,359	2,101	1,691
Prepaid Expenses	44.32	28.39	38.8	46.45	33.84	12.66
Other Current Assets	1,216	1,823	1,543	1,061	655.1	650.96
Total Current Assets	19,212	15,937	10,511	9,678	7,891	6,930
Property, Plant & Equipment	2,478	2,184	2,156	1,468	1,227	1,121
Long-Term Investments	16.15	15.92	-	-	-	-
Other Intangible Assets	216.32	219.02	30.18	15.3	6.9	8.49
Long-Term Deferred Tax Assets	137.59	114.4	82	59.39	11.58	9.26
Total Assets	22,067	18,550	12,864	11,284	9,250	8,170
Accounts Payable	4,914	3,661	1,593	1,399	917.38	1,222
Accrued Expenses	170.84	123.05	63.21	43.42	37.42	26.72
Short-Term Debt	3,376	3,165	2,290	1,568	607.9	276.91
Current Portion of Long-Term Debt	10,379	8,673	6,339	5,910	5,691	4,633
Current Portion of Leases	187.67	117.94	90.41	71.2	15.36	15.49
Current Income Taxes Payable	44.52	79.91	26.73	59.55	34.77	50.74
Current Unearned Revenue	33.92	17.96	16.77	15.32	-	-
Other Current Liabilities	94.16	85.74	50.93	335.18	149.79	146.23
Total Current Liabilities	19,200	15,924	10,470	9,401	7,454	6,370
Long-Term Debt	139.9	556.02	852.18	204.83	405.68	515.38
Long-Term Leases	1,089	620.42	281.67	224.8	26.27	34.12
Other Long-Term Liabilities	-	-	0	-	-	26.95
Total Liabilities	20,429	17,101	11,604	9,831	7,886	6,947
Common Stock	252	252	279.04	240	240	205
Additional Paid-In Capital	237.41	237.41	277.5	277.5	277.5	277.5
Retained Earnings	1,320	1,131	901.63	948.62	847.4	740.74
Treasury Stock	-171.64	-171.64	-198.69	-14.4	-	-
Total Common Equity	1,638	1,449	1,259	1,452	1,365	1,223
Minority Interest	0	0	0.39	1.77	0	-
Shareholders' Equity	1,638	1,449	1,260	1,453	1,365	1,223
Total Liabilities & Equity	22,067	18,550	12,864	11,284	9,250	8,170
Total Debt	15,171	13,133	9,853	7,979	6,746	5,474
Net Cash (Debt)	-13,961	-12,002	-9,312	-7,510	-6,475	-5,356
Net Cash Per Share	-13.85	-11.91	-9.24	-5.77	-5.78	-4.78
Filing Date Shares Outstanding	1,008	1,008	1,008	1,226	1,120	1,120
Total Common Shares Outstanding	1,008	1,008	1,008	1,226	1,120	1,120
Working Capital	11.9	12.98	41.39	276.74	437.88	560.3
Book Value Per Share	1.62	1.44	1.25	1.18	1.22	1.09
Tangible Book Value	1,422	1,230	1,229	1,436	1,358	1,215
Tangible Book Value Per Share	1.41	1.22	1.22	1.17	1.21	1.08
Land	93.75	93.75	93.75	93.75	93.75	93.75
Buildings	811.07	807.75	724.3	692.7	654.85	601.61
Machinery	847.88	828.47	648.61	612.95	539.63	428.37
Construction In Progress	219.42	427.51	944.81	242.88	219.92	160.91

Source: S&P Capital IQ. Standard template. Financial Sources.